norepinephrine bitartrate

(redirected from noradrenaline acid tartrate)

norepinephrine bitartrate

Levophed, Noradrenaline (UK)

Pharmacologic class: Sympathomimetic

Therapeutic class: Alpha- and beta-adrenergic agonist, cardiac stimulant, vasopressor

Pregnancy risk category C

FDA Box Warning

If extravasation occurs, infiltrate area promptly with 10 to 15 ml of saline solution containing 5 to 10 mg phentolamine to prevent sloughing and necrosis. Use syringe with fine hypodermic needle, and infiltrate solution liberally throughout area. Give phentolamine as soon as possible; its sympathetic blockade causes immediate local hyperemic changes if area is infiltrated within 12 hours.


Stimulates beta1 and alpha1 receptors in sympathetic nervous system, causing vasoconstriction, increased blood pressure, enhanced contractility, and decreased heart rate


Injection: 1 mg/ml

Indications and dosages

Severe hypotension

Adults: 8 to 12 mcg/minute I.V.; then titrate based on blood pressure response. For maintenance, 2 to 4 mcg/minute.


• Concurrent cyclopropane or halo-thane anesthesia

• Hypotension caused by blood volume deficit (except in emergencies until blood volume replacement is completed), profound hypoxia or hypercarbia

• Mesenteric or peripheral vascular thrombosis


Use cautiously in:

• sulfite sensitivity (some products), especially in asthmatic patients

• arterial embolism, cardiac disease, peripheral vascular disease, hypertension, hyperthyroidism

• patients receiving MAO inhibitors or tricyclic antidepressants concurrently

• elderly patients

• pregnant or breastfeeding patients

• children (safety and efficacy not established).


• Mix with dextrose 5% in water or dextrose 5% in normal saline solution.

• Inspect solution to make sure it's clear and colorless. Don't infuse if it's brown or pink.

• Administer through infusion pump. Titrate infusion rate to achieve and maintain low-normal systolic blood pressure (80 to 100 mm Hg).

• Continue infusion until adequate blood pressure and tissue perfusion persist without drug therapy.

• Gradually titrate dosage downward.

• To avoid extravasation, administer only into large vein (antecubital) or through central line. Don't use femoral vein in patients who are elderly or have occlusive vascular disorders.

To prevent delivery of large drug concentrations, avoid line stasis and flushing.

Adverse reactions

CNS: headache, anxiety

CV: bradycardia, severe hypertension, arrhythmias

Respiratory: respiratory difficulty

Skin: irritation with extravasation, necrosis

Other: ischemic injury


Drug-drug. Alpha-adrenergic blockers: antagonism of norepinephrine effects Antihistamines, ergot alkaloids, guanethidine, MAO inhibitors, oxytocin, tricyclic antidepressants: severe hypertension Bretylium, inhalation anesthetics: increased risk of arrhythmias

Patient monitoring

Check blood pressure every 2 minutes until desired pressure is achieved. Recheck every 5 minutes for duration of infusion.

• Maintain continuous ECG monitoring and blood pressure monitoring.

Be aware that headache may signal extreme hypertension and overdose.

• Monitor infusion site for extravasation.

Watch for signs and symptoms of peripheral vascular insufficiency (decreased capillary refill, pale to cyanotic to black skin color).

Never leave patient unattended during infusion.

Patient teaching

• When patient is alert, explain why he's receiving drug.

• Reassure patient he'll be monitored continuously until he's stable.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved

nor·ep·i·neph·rine bi·tar·trate

For actions and uses, see norepinephrine itself.
Farlex Partner Medical Dictionary © Farlex 2012

norepinephrine bitartrate

A standardized preparation of norepinephrine. The former name was levarterenol bitartrate.
See also: norepinephrine
Medical Dictionary, © 2009 Farlex and Partners